Loading stock data…
Ultralife Corporation (ULBI)
$5.30-0.08 (-1.49%)
Market ClosedLast close Jul 24
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Ultralife Corporation in the Industrials sector is trading at $5.30 with a market capitalization of $115M. The stock is currently near its 52-week low of $4.90, remaining 16.0% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 22) — potential for technical mean-reversion
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $47.45M↓ | $48.48M↑ | $43.37M↓ | $48.56M↓ | $50.75M |
| Gross Profit | $10.11M↓ | $12.06M↑ | $9.62M↓ | $11.60M↓ | $12.74M |
| Operating Income | -$215,000↓ | $1.57M↑ | -$951,000↓ | $2.26M↓ | $3.40M |
| Net Income | -$451,000↑ | -$7.42M↓ | -$1.22M↓ | $879,000↓ | $1.86M |
Peer Comparison
Fundamentals
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Syste...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$115.01M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-6.34%
Volume
Today's trading volume
16,293
Recent News
Zacks Initiates Coverage of Ultralife With Underperform Recommendation
Discover why Zacks rates Ultralife as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore ULBI's struggles with execution risks, margin pressure and commercialization delays that could delay its earnings recovery.
Ultralife (ULBI) Q1 2026 Earnings Transcript
Before turning the call over to management, I would like to remind everyone that some statements made during this conference call contain forward-looking statements based on current expectations. The company cautions investors not to place undue reliance on forward-looking statements, which reflect the company's analysis only as of today's date. The company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances.
Undervalued Small Caps With Insider Buying Across Regions
The United States market has experienced a flat week, yet it has shown a robust 27% increase over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this context of growth and stability, identifying stocks that are currently undervalued can offer potential opportunities for investors seeking to capitalize on insider confidence and regional strengths.
Undervalued Small Caps With Insider Activity To Consider In May 2026
Over the last 7 days, the United States market has risen by 2.6%, contributing to a significant 26% climb over the past year, with earnings forecasted to grow by 17% annually. In this environment of robust growth, identifying small-cap stocks that are potentially undervalued and exhibit insider activity can be an intriguing opportunity for investors seeking value in a dynamic market landscape.
Ultralife Corp (ULBI) Q1 2026 Earnings Call Highlights: Record Backlog Amid Revenue Challenges
Despite a challenging quarter with revenue declines, Ultralife Corp (ULBI) focuses on strategic growth initiatives and reports a record backlog of $115.1 million.